Taxanes: optimizing adjuvant chemotherapy for early-stage breast cancer
NATURE REVIEWS CLINICAL ONCOLOGY (2010)
期刊
NATURE REVIEWS CLINICAL ONCOLOGY
卷 7, 期 1, 页码 22-36出版社
NATURE PUBLISHING GROUP
关键词
类别
作者
我是这篇论文的作者
推荐
Adjuvant trastuzumab and vinorelbine for early-stage HER2+breast cancer
Shannon McLaughlin, Erika Nakajima, Yael Bar, Jennifer A. A. Hutchinson, Jennifer Shin, Beverly Moy, Steven J. J. Isakoff, Aditya Bardia, Irene Kuter, Laura M. M. Spring
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY (2023)
Perturbations of Adjuvant Chemotherapy on Cardiovascular Responses and Exercise Tolerance in Patients with Early-Stage Breast Cancer
Hsin-Fu Lin, Ching-Ying Tseng, Toby Mundel, Yi-Yuan Lin, Chung-Chi Lin, Chiao-Nan Chen, Yi-Hung Liao
BIOLOGY-BASEL (2021)
Biomarkers for Adjuvant Endocrine and Chemotherapy in Early-Stage Breast Cancer: ASCO Guideline Update
Fabrice Andre, Nofisat Ismaila, Kimberly H. Allison, William E. Barlow, Deborah E. Collyar, Senthil Damodaran, N. Lynn Henry, Komal Jhaveri, Kevin Kalinsky, Nicole M. Kuderer, Anya Litvak, Erica L. Mayer, Lajos Pusztai, Rachel Raab, Antonio C. Wolff, Vered Stearns
JOURNAL OF CLINICAL ONCOLOGY (2022)
Adjuvant capecitabine-containing chemotherapy benefit and homologous recombination deficiency in early-stage triple-negative breast cancer patients
Leonora W. de Boo, Katarzyna Jozwiak, Heikki Joensuu, Henrik Lindman, Susanna Lauttia, Mark Opdam, Charlaine van Steenis, Wim Brugman, Roelof J. C. Kluin, Philip C. Schouten, Marleen Kok, Petra M. Nederlof, Michael Hauptmann, Sabine C. Linn
BRITISH JOURNAL OF CANCER (2022)
Adjuvant tamoxifen adherence in men with early-stage breast cancer
Oluchi Oke, Jiangong Niu, Mariana Chavez-MacGregor, Hui Zhao, Sharon H. Giordano
CANCER (2022)
Real world evidence of adjuvant trastuzumab in HER2 positive early breast cancer
J. Lluch-Gomez, V. Nunez-Alvarez, C. de la Torre-Hita, M. Bernal-Gomez, A. Campini-Bermejo, E. Perdomo-Zaldivar, L. Rodriguez-Perez, J. Calvete-Candenas, M. J. Martinez-Bautista, E. Benitez-Rodriguez, J. M. Baena-Canada
SCIENTIFIC REPORTS (2023)
Adjuvant Capecitabine for Early Breast Cancer: 15-Year Overall Survival Results From a Randomized Trial
Heikki Joensuu, Pirkko-Liisa Kellokumpu-Lehtinen, Riikka Huovinen, Arja Jukkola, Minna Tanner, Johan Ahlgren, Paivi Auvinen, Outi Lahdenpera, Kenneth Villman, Paul Nyandoto, Greger Nilsson, Paula Poikonen-Saksela, Vesa Kataja, Petri Bono, Jouni Junnila, Henrik Lindman
JOURNAL OF CLINICAL ONCOLOGY (2022)
Selection of Optimal Adjuvant Chemotherapy and Targeted Therapy for Early Breast Cancer: ASCO Guideline Update
Neelima Denduluri, Mark R. Somerfield, Mariana Chavez-MacGregor, Amy H. Comander, Zoneddy Dayao, Andrea Eisen, Rachel A. Freedman, Ragisha Gopalakrishnan, Stephanie L. Graff, Michael J. Hassett, Tari A. King, Gary H. Lyman, Gillian Rice Maupin, Raquel Nunes, Cheryl L. Perkins, Melinda L. Telli, Maureen E. Trudeau, Antonio C. Wolff, Sharon H. Giordano
JOURNAL OF CLINICAL ONCOLOGY (2021)
Understanding divergent trial results of adjuvant CDK4/6 inhibitors for early stage breast cancer
Niamh C. Cunningham, Nicholas C. Turner
CANCER CELL (2021)
Perioperative Pembrolizumab for Early-Stage Non-Small-Cell Lung Cancer
Heather Wakelee, Moishe Liberman, Terufumi Kato, Masahiro Tsuboi, Se-Hoon Lee, Shugeng Gao, Ke-Neng Chen, Christophe Dooms, Margarita Majem, Ekkehard Eigendorff, Gaston L. Martinengo, Olivier Bylicki, Delvys Rodriguez-Abreu, Jamie E. E. Chaft, Silvia Novello, Jing Yang, Steven M. M. Keller, Ayman Samkari, Jonathan D. D. Spicer
NEW ENGLAND JOURNAL OF MEDICINE (2023)
Optimizing the Choice for Adjuvant Chemotherapy in Gastric Cancer
Antonino Grassadonia, Antonella De Luca, Erminia Carletti, Patrizia Vici, Francesca Sofia Di Lisa, Lorena Filomeno, Giuseppe Cicero, Laura De Lellis, Serena Veschi, Rosalba Florio, Davide Brocco, Saverio Alberti, Alessandro Cama, Nicola Tinari
CANCERS (2022)
Sequential vs concurrent adjuvant chemotherapy of anthracycline and taxane for operable breast cancer
Wanjing Chen, Qian Tu, Yanfei Shen, Kejun Tang, Mengying Hong, Yong Shen
WORLD JOURNAL OF SURGICAL ONCOLOGY (2021)
Adequacy of early-stage breast cancer systemic adjuvant treatment to Saint Gallen-2013 statement: the MCC-Spain study
Ines Gomez-Acebo, Trinidad Dierssen-Sotos, Monica Mirones, Beatriz Perez-Gomez, Marcela Guevara, Pilar Amiano, Maria Sala, Antonio J. Molina, Jessica Alonso-Molero, Victor Moreno, Claudia Suarez-Calleja, Ana Molina-Barcelo, Juan Alguacil, Rafael Marcos-Gragera, Maria Fernandez-Ortiz, Oscar Sanz-Guadarrama, Gemma Castano-Vinyals, Leire Gil-Majuelo, Conchi Moreno-Iribas, Nuria Aragones, Manolis Kogevinas, Marina Pollan, Javier Llorca
SCIENTIFIC REPORTS (2021)
Neoadjuvant and Adjuvant Systemic Therapy for Early-Stage Non-small-Cell Lung Cancer
James Isaacs, Thomas E. Stinchcombe
DRUGS (2022)
Chemotherapy-induced ovarian failure in young women with early breast cancer: Prospective analysis of four randomised neoadjuvant/adjuvant breast cancer trials
Jenny Furlanetto, Frederik Marme, Sabine Seiler, Christian Thode, Michael Untch, Sabine Schmatloch, Andreas Schneeweiss, Martina Bassy, Peter A. Fasching, Dominika Strik, Elmar Stickeler, Christian Schem, Thomas Karn, Eva-Maria Grischke, Carsten Denkert, Marion van Mackelenbergh, Volkmar Mueller, Valentina Nekljudova, Sibylle Loibl
EUROPEAN JOURNAL OF CANCER (2021)
Genomic Aberrations and Late Recurrence in Postmenopausal Women with Hormone Receptor-positive Early Breast Cancer: Results from the SOLE Trial
Elena Guerini-Rocco, Kathryn P. Gray, Caterina Fumagalli, Marta Rita Reforgiato, Isabella Leone, Paola Rafaniello Raviele, Elisabetta Munzone, Roswitha Kammler, Patrick Neven, Erika Hitre, Guy Jerusalem, Edda Simoncini, Andrea Gombos, Ines Deleu, Per Karlsson, Stefan Aebi, Jacquie Chirgwin, Vincenzo Di Lauro, Alastair Thompson, Marie-Pascale Graas, Matthew Barber, Christel Fontaine, Sibylle Loibl, Joaquin Gavila, Katsumasa Kuroi, Bettina Muller, Seamus O'Reilly, Angelo Di Leo, Aron Goldhirsch, Giuseppe Viale, Massimo Barberis, Meredith M. Regan, Marco Colleoni
CLINICAL CANCER RESEARCH (2021)
Clinical dilemmas in local and regional testis cancer
Gregory J. Nason, Ricardo A. Rendon, Lori Wood, Robert A. Huddart, Peter Albers, Lawrence H. Einhorn, Craig R. Nichols, Christian Kollmannsberger, Lynn Anson-Cartwright, Padraig Warde, Michael A. S. Jewett, Peter Chung, Philippe L. Bedard, Aaron R. Hansen, Robert J. Hamilton
CUAJ-CANADIAN UROLOGICAL ASSOCIATION JOURNAL (2021)
A Risk-benefit Analysis of Prophylactic Anticoagulation for Patients with Metastatic Germ Cell Tumours Undergoing First-line Chemotherapy
Christian Daniel Fankhauser, Ben Tran, Manuel Pedregal, Jose Manuel Ruiz-Morales, Egon Gonzalez-Billalabeitia, Anna Patrikidou, Eitan Amir, Christoph Seidel, Carsten Bokemeyer, Thomas Hermanns, Alexey Rumyantsev, Alexey Tryakin, Margarida Brito, Aude Flechon, Edmon M. Kwan, Tina Cheng, Daniel Castellano, Xavier Garcia Del Muro, Anis A. Hamid, Margaret Ottaviano, Giovanella Palmieri, Robert Kitson, Alison Reid, Daniel Y. C. Heng, Philippe L. Bedard, Christopher J. Sweeney, Jean M. Connors
EUROPEAN UROLOGY FOCUS (2021)
Pharmacokinetics and Safety of PTC596, a Novel Tubulin-Binding Agent, in Subjects With Advanced Solid Tumors
Geoffrey I. Shapiro, Edward O'Mara, Oscar L. Laskin, Lan Gao, John D. Baird, Robert J. Spiegel, Diksha Kaushik, Marla Weetall, Joseph Colacino, Kylie O'Keefe, Arthur Branstrom, Elizabeth Goodwin, Jeffrey Infante, Philippe L. Bedard, Ronald Kong
CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT (2021)
Endocrine-Based Treatments in Clinically-Relevant Subgroups of Hormone Receptor-Positive/HER2-Negative Metastatic Breast Cancer: Systematic Review and Meta-Analysis
Francesco Schettini, Mario Giuliano, Fabiola Giudici, Benedetta Conte, Pietro De Placido, Sergio Venturini, Carla Rognoni, Angelo Di Leo, Mariavittoria Locci, Guy Jerusalem, Lucia Del Mastro, Fabio Puglisi, PierFranco Conte, Michelino De Laurentiis, Lajos Pusztai, Mothaffar F. Rimawi, Rachel Schiff, Grazia Arpino, Sabino De Placido, Aleix Prat, Daniele Generali
CANCERS (2021)
Chemotherapy and Targeted Therapy for Patients With Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer That is Either Endocrine-Pretreated or Hormone Receptor-Negative: ASCO Guideline Update
Beverly Moy, R. Bryan Rumble, Steven E. Come, Nancy E. Davidson, Angelo Di Leo, Julie R. Gralow, Gabriel N. Hortobagyi, Douglas Yee, Ian E. Smith, Mariana Chavez-MacGregor, Rita Nanda, Heather L. McArthur, Laura Spring, Katherine E. Reeder-Hayes, Kathryn J. Ruddy, Paul S. Unger, Shaveta Vinayak, William J. Irvin, Avan Armaghani, Michael A. Danso, Natalie Dickson, Sophie S. Turner, Cheryl L. Perkins, Lisa A. Carey
JOURNAL OF CLINICAL ONCOLOGY (2021)
Genomic and Transcriptomic Analyses of Breast Cancer Primaries and Matched Metastases in AURORA, the Breast International Group (BIG) Molecular Screening Initiative
Philippe Aftimos, Mafalda Oliveira, Alexandre Irrthum, Debora Fumagalli, Christos Sotiriou, Einav Nili Gal-Yam, Mark E. Robson, Justin Ndozeng, Angelo Di Leo, Eva M. Ciruelos, Evandro de Azambuja, Giuseppe Viale, Elsemieke D. Scheepers, Giuseppe Curigliano, Judith M. Bliss, Jorge S. Reis-Filho, Marco Colleoni, Marija Balic, Fatima Cardoso, Joan Albanell, Caroline Duhem, Sandrine Marreaud, Dario Romagnoli, Beatriz Rojas, Andrea Gombos, Hans Wildiers, Angel Guerrero-Zotano, Peter Hall, Andrea Bonetti, Karolina Fs Larsson, Martina Degiorgis, Silvia Khodaverdi, Richard Greil, Asgerdur Sverrisdottir, Marta Paoli, Ethel Seyll, Sibylle Loibl, Barbro Linderholm, Gabriele Zoppoli, Nancy E. Davidson, Oskar Th Johannsson, Philippe L. Bedard, Sherene Loi, Susan Knox, David A. Cameron, Nadia Harbeck, Maite Lasa Montoya, Mariana Brandao, Andrea Vingiani, Carmela Caballero, Florentine S. Hilbers, Lucy R. Yates, Matteo Benelli, David Venet, Martine J. Piccart
CANCER DISCOVERY (2021)
The prognostic relevance of HER2-positivity gain in metastatic breast cancer in the ChangeHER trial
Laura Pizzuti, Maddalena Barba, Marco Mazzotta, Eriseld Krasniqi, Marcello Maugeri-Sacca, Teresa Gamucci, Rossana Berardi, Lorenzo Livi, Corrado Ficorella, Clara Natoli, Enrico Cortesi, Daniele Generali, Nicla La Verde, Alessandra Cassano, Emilio Bria, Luca Moscetti, Andrea Michelotti, Vincenzo Adamo, Claudio Zamagni, Giuseppe Tonini, Domenico Sergi, Daniele Marinelli, Giancarlo Paoletti, Silverio Tomao, Andrea Botticelli, Paolo Marchetti, Nicola Tinari, Antonino Grassadonia, Maria Rosaria Valerio, Rosanna Mirabelli, Maria Agnese Fabbri, Nicola D'Ostilio, Enzo Veltri, Domenico Corsi, Ornella Garrone, Ida Paris, Giuseppina Sarobba, Icro Meattini, Mirco Pistelli, Francesco Giotta, Vito Lorusso, Carlo Garufi, Antonio Russo, Marina Cazzaniga, Pietro Del Medico, Mario Roselli, Angela Vaccaro, Letizia Perracchio, Anna di Benedetto, Theodora Daralioti, Isabella Sperduti, Ruggero De Maria, Angelo Di Leo, Giuseppe Sanguineti, Gennaro Ciliberto, Patrizia Vici
SCIENTIFIC REPORTS (2021)
Circulating Biomarkers of CDK4/6 Inhibitors Response in Hormone Receptor Positive and HER2 Negative Breast Cancer
Ilenia Migliaccio, Angela Leo, Francesca Galardi, Cristina Guarducci, Giulio Maria Fusco, Matteo Benelli, Angelo Di Leo, Laura Biganzoli, Luca Malorni
CANCERS (2021)
A Serum Metabolomics Classifier Derived from Elderly Patients with Metastatic Colorectal Cancer Predicts Relapse in the Adjuvant Setting
Samantha Di Donato, Alessia Vignoli, Chiara Biagioni, Luca Malorni, Elena Mori, Leonardo Tenori, Vanessa Calamai, Annamaria Parnofiello, Giulia Di Pierro, Ilenia Migliaccio, Stefano Cantafio, Maddalena Baraghini, Giuseppe Mottino, Dimitri Becheri, Francesca Del Monte, Elisangela Miceli, Amelia McCartney, Angelo Di Leo, Claudio Luchinat, Laura Biganzoli
CANCERS (2021)
Heparanase: a potential marker of worse prognosis in estrogen receptor-positive breast cancer
Tamar Zahavi, Mali Salmon-Divon, Roberto Salgado, Michael Elkin, Esther Hermano, Ariel M. Rubinstein, Prudence A. Francis, Angelo Di Leo, Giuseppe Viale, Evandro de Azambuja, Lieveke Ameye, Christos Sotiriou, Asher Salmon, Nataly Kravchenko-Balasha, Amir Sonnenblick
NPJ BREAST CANCER (2021)
Utility of Serum miR-371a-3p in Predicting Relapse on Surveillance in Patients with Clinical Stage I Testicular Germ Cell Cancer
Joao Lobo, Ricardo Leao, Ad J. M. Gillis, Annette van den Berg, Lynn Anson-Cartwright, Eshetu G. Atenafu, Kopika Kuhathaas, Peter Chung, Aaron Hansen, Philippe L. Bedard, Michael A. S. Jewett, Padraig Warde, Martin O'Malley, Joan Sweet, Leendert H. J. Looijenga, Robert J. Hamilton
EUROPEAN UROLOGY ONCOLOGY (2021)
Long-term Surveillance of Patients with Complete Response Following Chemotherapy for Metastatic Nonseminomatous Germ Cell Tumor
Gregory J. Nason, Michael A. S. Jewett, Peter J. Bostrom, Hanan Goldberg, Aaron R. Hansen, Philippe L. Bedard, Jeremy Sturgeon, Padraig Warde, Peter Chung, Lynn Anson-Cartwright, Joan Sweet, Eshetu G. Atenafu, Martin O'Malley, Robert J. Hamilton
EUROPEAN UROLOGY ONCOLOGY (2021)
Circulating tumor cells and palbociclib treatment in patients with ER-positive, HER2-negative advanced breast cancer: results from a translational sub-study of the TREnd trial
Francesca Galardi, Francesca De Luca, Chiara Biagioni, Ilenia Migliaccio, Giuseppe Curigliano, Alessandro M. Minisini, Martina Bonechi, Erica Moretti, Emanuela Risi, Amelia McCartney, Matteo Benelli, Dario Romagnoli, Silvia Cappadona, Stefano Gabellini, Cristina Guarducci, Valerio Conti, Laura Biganzoli, Angelo Di Leo, Luca Malorni
BREAST CANCER RESEARCH (2021)
Phase I Basket Study of Taselisib, an Isoform-Selective PI3K Inhibitor, in Patients with PIK3CA-Mutant Cancers
Komal Jhaveri, Matthew T. Chang, Dejan Juric, Cristina Saura, Valentina Gambardella, Anton Melnyk, Manish R. Patel, Vincent Ribrag, Cynthia X. Ma, Raid Aljumaily, Philippe L. Bedard, Jasgit C. Sachdev, Lara Dunn, Helen Won, John Bond, Surai Jones, Heidi M. Savage, Maurizio Scaltriti, Timothy R. Wilson, Michael C. Wei, David M. Hyman
CLINICAL CANCER RESEARCH (2021)